/IRMD
IRMD Stock - IRadimed Corporation
Healthcare|Medical - DevicesNASDAQ
$97.19+0.88%
+$0.85 (+0.88%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).48
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.77
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-1.2%upside
Target: $96.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IRMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$96.22 – $98.16
TARGET (TP)$96.00
STOP LOSS$89.41
RISK/REWARD1:-0.2
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.08
52W High$98.44
52W Low$47.48
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $73.24M | $65.56M | $53.30M | $41.81M | $31.72M |
| Gross Profit | $56.35M | $50.16M | $41.28M | $32.05M | $23.57M |
| Gross Margin | 76.9% | 76.5% | 77.4% | 76.6% | 74.3% |
| Operating Income | $21.96M | $20.04M | $15.63M | $9.82M | $-756,091 |
| Net Income | $19.23M | $17.19M | $12.83M | $9.33M | $1.37M |
| Net Margin | 26.3% | 26.2% | 24.1% | 22.3% | 4.3% |
| EPS | $1.52 | $1.36 | $1.02 | $0.76 | $0.11 |
Company Overview
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$50
Average Target
↓ 48.6% Downside
Now
$50
Low
$50
Average
$50
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| April 12th 2023 | Lake Street | Initiation | Buy | $50 |
Earnings History & Surprises
IRMDBeat Rate
78%
Last 18 quarters
Avg Surprise
+13.4%
EPS vs Estimate
Beats / Misses
14/4
Last 12 quarters
Latest EPS
$0.47
Q4 2025
EPS Surprise History
Q1 24
-2.5%
$0.39vs$0.40
Q2 24
+5.9%
$0.36vs$0.34
Q3 24
+13.5%
$0.42vs$0.37
Q4 24
+10.3%
$0.43vs$0.39
Q1 25
-2.2%
$0.44vs$0.45
Q2 25
-2.3%
$0.42vs$0.43
Q3 25
+8.9%
$0.49vs$0.45
Q4 25
-2.1%
$0.47vs$0.48
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | $0.49 | — | — | — |
Q4 2025 | Nov 3, 2025 | $0.48 | $0.47 | -2.1% | ✗ MISS |
Q3 2025 | Aug 1, 2025 | $0.45 | $0.49 | +8.9% | ✓ BEAT |
Q2 2025 | May 5, 2025 | $0.43 | $0.42 | -2.3% | ✗ MISS |
Q1 2025 | Feb 13, 2025 | $0.45 | $0.44 | -2.2% | ✗ MISS |
Q4 2024 | Oct 31, 2024 | $0.39 | $0.43 | +10.3% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $0.37 | $0.42 | +13.5% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.34 | $0.36 | +5.9% | ✓ BEAT |
Q1 2024 | Feb 8, 2024 | $0.40 | $0.39 | -2.5% | ✗ MISS |
Q4 2023 | Nov 3, 2023 | $0.36 | $0.43 | +19.4% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.31 | $0.36 | +16.1% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.28 | $0.30 | +7.1% | ✓ BEAT |
Q1 2023 | Feb 2, 2023 | $0.30 | $0.32 | +6.7% | ✓ BEAT |
Q4 2022 | Nov 3, 2022 | $0.25 | $0.29 | +16.0% | ✓ BEAT |
Q3 2022 | Jul 29, 2022 | $0.24 | $0.26 | +8.3% | ✓ BEAT |
Q2 2022 | Apr 29, 2022 | $0.21 | $0.22 | +4.8% | ✓ BEAT |
Q1 2022 | Feb 4, 2022 | $0.21 | $0.33 | +57.1% | ✓ BEAT |
Q4 2021 | Oct 29, 2021 | $0.17 | $0.23 | +35.3% | ✓ BEAT |
Q3 2021 | Jul 30, 2021 | $0.10 | $0.14 | +40.0% | ✓ BEAT |
Latest News
iRadimed Declares $0.50/Share Special Cash Dividend Payable December 30, 2025
📈 PositiveBenzinga•Dec 8, 2025, 01:43 PM
iRadimed Sees Q4 GAAP EPS $0.43-$0.47 vs $0.41 Est
📈 PositiveBenzinga•Nov 3, 2025, 01:36 PM
iRadimed Sees Q4 Adj EPS $0.47-$0.51 vs $0.47 Est; Sees Sales $21.400M-$22.400M vs $20.733M Est
📈 PositiveBenzinga•Nov 3, 2025, 01:35 PM
iRadimed Raises FY2025 GAAP EPS Guidance from $1.60-$1.70 to $1.68-$1.72 vs $1.65 Est
📈 PositiveBenzinga•Nov 3, 2025, 01:35 PM
iRadimed Raises FY2025 Adj EPS Guidance from $1.76-$1.86 to $1.84-$1.88 vs $1.82 Est; Raises FY2025 Sales Guidance from $80.000M-$82.500M to $82.500M-$83.500M vs $81.091M Est
📈 PositiveBenzinga•Nov 3, 2025, 01:35 PM
iRadimed Q3 Adj. EPS $0.47 Beats $0.46 Estimate, Sales $21.202M Beat $20.498M Estimate
📈 PositiveBenzinga•Nov 3, 2025, 01:33 PM
Iradimed rises after FDA nod for infusion pump system
📈 PositiveSeeking Alpha•May 29, 2025, 02:55 PM
Frequently Asked Questions about IRMD
What is IRMD's current stock price?
IRadimed Corporation (IRMD) is currently trading at $97.19 per share. The stock has moved +0.88% today.
What is the analyst price target for IRMD?
The average analyst price target for IRMD is $96.00, based on 1 analyst.
What sector is IRadimed Corporation in?
IRadimed Corporation operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is IRMD's market cap?
IRadimed Corporation has a market capitalization of $1.24 billion, making it a small-cap company.
Does IRMD pay dividends?
No, IRadimed Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAHCO
AdaptHealth Corp.
$9.97
Mkt Cap: $1.4B
AXGN
AxoGen, Inc.
$31.98
Mkt Cap: $1.5B
CRON
Cronos Group Inc.
$2.96
Mkt Cap: $1.1B
CTEV
Claritev Corporation
$41.02
Mkt Cap: $0.7B
GDRX
GoodRx Holdings, Inc.
$2.77
Mkt Cap: $0.9B
IART
Integra LifeSciences Holdings Corporation
$12.65
Mkt Cap: $1.0B
INMD
InMode Ltd.
$14.36
Mkt Cap: $1.0B
MDXG
MiMedx Group, Inc.
$7.05
Mkt Cap: $1.0B
OPK
OPKO Health, Inc.
$1.31
Mkt Cap: $1.0B
TNDM
Tandem Diabetes Care, Inc.
$22.07
Mkt Cap: $1.5B
Explore stocks similar to IRMD for comparison